Options Trading Strategies Newsletter

Options Trading Alerts  

Options Trading Strategies Newsletter 

Read the November 9, 2015 Where To invest Now and Options Trading Newsletter in .pdf format – Click Here

November 8, 2015

Market Strategies Newsletter

 Options Trading Newsletter

Sample Issue



Balanced Investing Strategies To

Make Money In Up Or Down Markets


A Publication of Princeton Research, Inc. (www.PrincetonResearch.com)

Contributing Staff: Michael King, Charles Moskowitz


Where To Invest Your Money Now Newsletter


Options Trading Alerts   

Gain For The Week $ 497


2015 YTD Profits $ 8922

Over 89% Returns


2014 Profits = $ 20,443

Over 204% Returns



NOTE: This is a Sample Issue Only!



Visit: PrincetonResearch.com/join.htm




For Free Where To Invest Your Money Now

High Return Investments Trade Alerts

Go To: PrincetonResearch.com/alerts.htm


$10,000 Trading Portfolio
Charles Moskowitz Discussion


We Have 4 Long Open Positions:


ETSY Nov 10 Calls

NE Nov 14 Calls

SUN Dec 40 Calls and

TWTR  Dec 30 Calls


Funds in Use = $1,667                                        

Where To Invest options trading news

Options Trading Strategies Newsletter

Week 45 produced a gain of $497, bringing our YTD gain up to a new yearly high of $8922.

We have 4 open positions using a total of $1667.  The open positions in both NE and TWTR are actually the balance of trades that were opened and hit the 100% Up rule the first day.


I continue to make trades on the long side of this market while keeping a very close eye on any weakness.  I gave up the position in the TBT calls a little early but with good gains in a market that I felt had shifted from oversold to overbought.  Even if the Fed does raise rates in December the bonds seem to have already factored it in.  A couple of weeks ago I stated that the December 30-year chart (@ 157-158) could test the September lows around 152.  We traded the XLF (financials) calls very profitably and kept the TBT (bond short) position.  Friday’s low for the Dec. bonds was 151 25/32, just under the support from the Sept. 17th low.  I have very little concern about selling too early, as bond yields tend to trend once a new direction has been established.  If that has happened, we’ll have plenty of time and chances to participate. The market that is suffering the most seems to be the Gold.  Since it provides no yield, it tends to trade lower while rates are rising.  You have to own it, and store it, and that just doesn’t make any sense if its price isn’t moving up.  The comparison with a US government obligation with a good yield is clearly preference.


In looking at the S&P500 chart it seems to me that this rally straight up from the double bottom low in September @ 1871 has run its course.  Even though we keep grinding higher we have not had more than a 3-4 day consolidation or pullback for 6 weeks.  The list of new highs has diminished and the rally keeps getting more and more narrow.  I’m not bearish, but as Mike discusses in the Cycles section today we are coming into a period of under- performance for the next week or so.

For that reason I am much more likely to favor the short side, or at least cut back on new long positions.  I was clearly too early on the IWM (Russell) short last week and it caused the only loss for the week.


The politics are a non-starter for me.  Of course we are going to see many of the possible candidates fall by the wayside.  The Sunday shows had very little to even discuss this week.  On the international front there are a continuously growing number of conflicts involving Russia, Syria, and now Egypt.  There is no shortage of issues that could cause a downdraft back from the close @ 2099 to the support around 2050 or even 2020.  So, between the cycles and the overbought nature of the market,  I’m cautious..CAM.


Options Trading Alerts  

Market Strategies $10,000 Trading Account Trade Table


New Trades


  ( 1 ) Buy 4 CONN November 23 Calls @ $ 1.30

  ( 2 ) Buy 6 TJX December 75 Calls @ $ 1.10

  ( 3 ) Buy 4 UAL December 62.50 Calls @ $ 1.95


Sold  3 TBT November 43 Calls
       225 Gain
Bought 6 ETSY November 10 Calls
Sold 3 TBT November 43 Calls
       225 Gain
Sold  6 IWM November 113 Puts
       198 Loss
Sold 5 NE Nov 14 Calls ( 100% Profit Rule )
       245 Gain
Bought 6 IWM November 113 Puts
Bought 10 NE November 14 Calls
Sold 3 TWTR December 30 Calls ( 100% Profit Rule ) Three lots remain Open
       402 Gain
Bought 6 TWTR December 30 Calls
Bought 8 SUN December  40 Calls
Bought 6 TBT  November 43  Calls


Remember, these trades are based on your participation in the

Subscriber Members Only




Previous closed out trades not listed here may be seen in previous market letters in the

VIP Subscribers Members Area.



For Free Where To Invest Your Money Now

High Return Investments Trade Alerts

Go To: PrincetonResearch.com/alerts.htm



Options Trading Newsletter

Options Trading Strategies

Options trading Newsletter

MARKET Laboratory – Weekly Changes

Prices are copied from Barron’s Weekly and Yahoo Finance and may be incorrect.








S&P 500








Russell 2000








Gold (spot)












Heating Oil




Unleaded Gas




Natural Gas








Put/Call Ratios

S&P 100



Put/Call Ratios

CBOE Equity





152-10 -4-04

3.09% +0.16%

10 Yr. Note

126-014-1-21         2.33%+0.19%






CRB Inflation





Barron’s* Confidence







5 Yr. Note

118-224 -1-023

1.73% +0.21%






DJ Utilities








Long Term



39.0 %














M1 Money  Supply


Oct 26th




M-2 Money



Oct 26th




* Component Change in the Confidence Index


M1…all money in hands of the public, Time Deposits Traveler’s Checks, Demand Deposits
M2.. adds Savings and Money Market Accounts both compared with the previous year.


Where to invest your money now

Market Strategies Technical Information


Support/Resistance Levels:                SUPPORT                         RESISTANCE


S&P 500             2039                                   2116

Dow                 17,345                                 18,088

QQQ            108.10                                 116.90

Transports        80.79                                   8307

NASDAQ           4899                                5248



$100,000 Trading Portfolio Stock Positions and Trades


Each stock is allocated a theoretical $ 5,000 share of the portfolio unless otherwise indicated.  


Additional New Stock Trades will be Texted


Each stock is allocated a theoretical $ 5,000 share of the portfolio unless otherwise indicated.





Purchase Price Purchase Date Stop/Loss   Price/Date Sold   Profit/


SPXU   100 30.08       11/02
EIGI      500 10.72       11/02 12.80 11/6 $ 1040
EYES  1000   6.36       11/02 7.84   11/3

6.92   11/5

$   740

$   280

TWTR  200 28.51       10/28
SPXU  200 34.10       10/15
CUBA   500   7.58       09/28
MOS  100 43.55       08/14
CRM  100 72.90       04/29      66.25
NBG  600 1.40       02/17
BAC. Wts 5,000 lots 0.7411       12/26
BSBR  500






SAN  600 8.40      12/16
AA  500 14.21      10/16
FCX 150 34.99      09/09    7.75
NBG 300   2.95      05/19
NBG 300 4.08 8/12
TEXQY* 200 6.56 7/11
REPR* 5000 0.22 10/22/12


Remember, these trades are based on your participation in the

Subscriber Members Only




Previous closed out trades not listed here may be seen in previous market letters in the

VIP Subscribers Members Area.

For those of you who do not buy puts to protect your portfolio, there are many ETF’s that are the inverse of the DOW. The symbols are DOG, DXD, SDS,TZA and RWM, which go up when the  DOW, S&P 500 and Russell 2000 go down and down when they go up. The DZZ goes up double when gold goes down.




For Free Where To Invest Your Money Now

High Return Investments Trade Alerts

Go To: PrincetonResearch.com/alerts.htm

Market Strategies $100,000 Trading Account


             New Options Trades:


             ( 1 ) Buy 8 CONN November 23 Calls @ $ 1.30

             ( 2 ) Buy 12 TJX December 75 Calls @ $ 1.10

             ( 3 ) Buy  8 UAL December 62.50 Calls @ $ 1.95


There were five closed option positions including the covered Call:


16 NE Nov 113 Puts were sold on the 100% Profit Rule making $ 490

12 TBT Calls were sold in two tranches: first on the Nov 3rd gaining $ 450.

The second two days later the same $ 450

IWM Puts were sold the same day bought on Nov 2nd losing $ 394.

SPXU Nov 33 Covered Calls were bought at $ 0.26 for a debit to the account of 52.


The options total for the week was a profit of $ 942.


There were two closed out stock positions:


EYES making $ 740 and $ 280 sold separately and the

EIGI making $ 1014 totaling $ 2,060.


For the year to date we have gains of $ 23,519. 


Open position losses decreased by $ 277 to $ 14,294.


The options expire on the third Friday of each Month unless otherwise posted.


The Stock table has the following 17 positions:





The options call for a $ 2,500 investment unless otherwise stated; each stock position requires $5,000 unless otherwise mentioned specifically.


We are basing money management on a hypothetical

$ 100,000 and are using a total of

$   61,721 for the 17 open stock positions. There are four long option positions requiring

$     3,100 which added to the stock longs totals an outlay of

$   64,821 leaving

$   35,179 in cash.


The four long open options positions in the table below are:


12 ETSY; 10 NE;  6 TWTR and 16 SUN.


These figures are approximate and there might be errors.


We have not counted the dividends received from Apple, JP Morgan, North American Tankers, Santander, their Brazil affiliate BSBR and Blue Capital Reinsurance which was sold for a profit and many others.


Executions that have occurred at or near the open or close of trading sometimes vary from our actual numbers.  For example, when something opens down and it is through our price, we take the next trade whether it is an uptick or continues lower.  This sometimes results in a 50% trade that is slightly above or below the exact number.



For Free Where To Invest Your Money Now

High Return Investments Trade Alerts

Go To: PrincetonResearch.com/alerts.htm


Previous Week’s Recommendations and

Rules for the Market Strategies

$100,000 Portfolio Trading Account


  • All options count for about $ 2,500.00 for model portfolio calculations unless

otherwise stated


  • When the option has doubled sell half the position


  • Stop Loss protection is either half or offered with each trade


  • The cost of the option is the asking price (or the price between the bid and ask,

whichever is more realistic)


  • The options will be followed until closed out.


  • Option Symbols are stock symbol with expiration month and strike price


Option Cost Date Sold Date Profit/


ETSY Nov 10

12 lots



IWM Nov 113

12 lots closed



11/02/15 0.49 11/02/2015 ( $ 396 )
NE Nov 14

20 lots

10 lots Open



11/02/15 0.98

Sold Half 100% Profit Rule

11/02/2015 $ 490
TWTR Dec 30

6 lots Open



10/28/15 2.68

Sold Half 100% Profit Rule

10/28/2015 $ 804
SUN Dec 40

16 lots



TBT Nov 43

30 lots



10/19/15 2.05




$ 450

$ 450

SPXU Nov 33

Closed out



10/16/15 0.26

Debit against long



$ 410

( $ 52 )


Remember, these trades are based on your participation in the

Subscriber Members Only




Previous closed out trades not listed here may be seen in previous market letters in the

VIP Subscribers Members Area.



This Weeks’ Economic Numbers

Earnings Releases and Media Data


Before the Open on top of the Row;

After the close below the Economics Information


MONDAY Arch Coal ACI ( -5.53 vs -0.45 ) Dean Foods DF ( 0.24 vs -0.03 ) Dish Network  

( 0.38 vs 0.31 ) Hertz Global  HTZ ( 0.54 ) Priceline PCLN ( 24.24 vs 22.16 ) Travel Centers of America TA ( 0.32 vs 0.34 ) Regal-Beloit RBC ( 1.43 vs 1.15 )


Caesars Entertainment CZR ( 0.66 vs -6.29 ) International Flavors IFF 1.35 vs 1.32  McDermott MDR ( -0.05 vs -0.14 ) Rackspace RAX ( 0.20 vs 0.18 ) Tutor Perini TPC ( 0.78 vs 0.73 ) UGI Corp UGI ( -0.02 vs -0.08 ) ViaSat VSAT ( 035 vs 0.68 )

TUESDAY Aecom Tech ACM ( 0.92 vs 0.79 ) AerCap AER ( 1.53 vs 1.49 ) Int Gaming Tech IGT ( 0.31 vs 0.37 ) Beazer Homes BZH ( 0.85 vs 1.90 ) Canadian Solar CSIQ

( 0.29 vs 1.75 ) DR Horton DHI ( 0.63 vs 0.45 ) Rockwell ROK  ( 1.78  vs 1.86 )

10:00 hrs Export Prices ex-ag October  ( NA vs -0.6% )

10:00 hrs Import Prices ex-oil  October  ( NA vs -0.3% )

10:00 hrs Wholesale Inventories Sept ( 0.1% vs 0.1% )

Amdocs DOX ( 0.82 vs 0.78 ) China Lodging HTHT ( 2.46 vs 2.61 ) Kinross Gold

KGC ( -0.03 vs -0.00 ) Westport Innovations WPRT ( -0.25 vs -0.40 )

WEDNESDAY ADT ADT ( 0.48 vs 0.55 ) CGI Group GIB ( 0.79 vs 0.73 ) Macy’s M 0.53 vs 0.61

Nordic American Tanker NAT ( 0.27 vs 0.12 ) Tuniu TOUR ( -3.41 vs -0.69 )

07:00 hrs  MBA Mortgage Index  10/31   ( NA vs -3.5% )

08:15 hrs  ADP Employment Change Oct  ( 180K vs 200K )

08:30 hrs Trade Balance September ( -$43.0Blm vs -$48.3Bln )

10:00 hrs  ISM Services  Oct ( 56.6 vs 56.9 )

Civitas Solutions CIVI ( 0.18 ) Flowers Foods FLO ( 0.23 vs 0.21 ) Franco-Nevada Corp FNV ( 0.12 vs 0.23 ) Roundy’s RNDY ( -0.09 vs -0.07 ) Shell Midstream Partners SHLX  ( 0.29 )  Synacor SYNC ( -0.07 vs -0.09 ) Smart and Final Stores SFS ( 0.22 vs 0.24 ) Spartan Nash SPTN ( 0.49 vs 0.46 )

THURSDAY Advance Auto AAP ( 2.09 vs 1.89 ) Diana Shipping DSX ( -0.19 vs 0.08 ) CPI Card Group PMTS ( 0.36 ) Dillards DDS ( 1.25 vs 1.30 ) Kohls KSS ( 0.71 vs 0.70 )

Israel Chemical ICL 0.15 Netsol NTWK ( -0.12 vs -0.20 ) Sally Beauty SBH ( 0.39 vs 0.39 ) Viacom VIAB ( 1.55 vs 1.71 ) Transdigm Group TDG ( 2.57 vs 2.21 )  

07:00 hrs MBA Mortgage Index 11/07 ( NA vs -0.8% )

08:30 hrs Initial Claims 11/07  ( 269K vs  262K )

08:30 hrs Continuing Claims 10/31 ( 2155K vs 2146K )

10:00 hrs JOLTS – Job Openings September ( NA vs 5.4Mln )

11:00 hrs Crude Inventories 10/07 ( NA vs +2.85Mln Bbls )

14:00 hrs Treasury Budget Oct ( -$130.0B vs -$121.7B )

Cisco Systems  ( 0.56 vs 0.54 ) Applied Materials AMAT ( 0.29 vs 0.27 )              

Blue Buffalo BUFF ( 0.14 )  Planet Fitness PLNT ( 0.09 ) Nordstrom JWN ( 0.73 vs 0.73 ) Youku Tudou YOKU ( -0.18 vs -0.08 ) Ryerson RYI ( 0.18 vs -1.26 )

FRIDAY Berry Plastics BERY 0.46 J.C. Penney JCP ( -0.56 vs -0.77 ) Edgewell Personal Care EPC ( 0.70 ) Joint Corp JYNT ( – 0.27 ) Tyco TYC 0.61 vs 0.56 )

08:30 hrs PPI Oct ( 0.1% vs -0.5% )

CORE PPI Oct ( 0.1% vs -0.3% )

08:30 hrs Retail Sales Oct ( +0.3% vs 0.1% )

08:30 hrs Retail Sales Ex- Auto ( +0.4% vs -0.3% )

10:00 hrs Michigan Sentiment Nov ( 92.0 vs NA )

10:00 hrs Business Inventories Sept ( 0.0% vs 0.0% )

10:30 hrs Natural Gas Inventories 11/07  ( NA vs 52 bcf )

WGL Holdings WGL ( -0.35 vs -0.17 )



Market Strategies Fundamentals


Treasuries suffered heavy losses last week leading up to a very surprising jobs report and then a big jolt upon the announcement of huge employment gains well above expectations.  The Fed fund futures now indicate a 70% chance of a rate hike at the December meeting, up from 56% prior to the release. The yield curve steepened somewhat, with the 2-year note holding up better than the other maturities. The U.S. Dollar Index spiked immediately after the announcement trading up 1.26% to 99.17. St Louis Fed President James Bullard said after the release that he saw a probability of a December rate hike at 80%. He does not currently vote on the FOMC but will vote is 2016.

Stocks on the other hand had a positive week led by the Russell 2000 gaining 37.88 points to 1199.75 up 3.26%. Nasdaq followed with a gain of 93.37 points to 5147.12, up 1.85%. The Dow added 246.79 points to 17.910.33, up 1.40%. The Transportation Index gained 113.36 points to 8,241.43, up 1.39% while the S&P 500 added 19.84 points to 2099.20 positive by 0.95%.The lesser known QQQ rallied to a new all- time high at 114.79 up 1.3% on the week. The index is led by Apple comprising 12.83% of the index. Microsoft is next at 8.14%; then Amazon 5.58%; Alphabet 4.68% Facebook 4.58%. Those fab  five stocks comprise 36% of the QQQ Index.

As shown below, the earnings beat rate (% of companies that have beaten consensus analyst EPS estimates) is now at 63%, which would be the strongest reading we’ve seen since Q4 2010, if it holds.

Top line revenues have not kept up with earnings which together with the election year typical weakness could cause concern as the market tries to take out the highs set in May.


Best Stocks To Buy

Market Strategies Economic Data

Nonfarm payrolls increased by 271,000 (Briefing.com consensus 181,000). September nonfarm payrolls revised to 137,000 from 142,000. August nonfarm payrolls revised to 153,000 from 136,000. Private sector payrolls increased by 268,000 (Briefing.com consensus 160,000). September private sector payrolls revised to 149,000 from 118,000. August private sector payrolls revised to 125,000 from 100,000.

Unemployment rate was 5.0% (Briefing.com consensus 5.1%) versus 5.1% in September. The U6 unemployment rate, which accounts for the total unemployed plus persons marginally attached to the labor force and the underemployed, was 9.8% versus 10.0% in September. Persons unemployed for 27 weeks or more accounted for 26.8% of the unemployed versus 26.6% in September.

Average hourly earnings increased 0.4% (Briefing.com consensus 0.2%) after being unchanged in September. Aggregate earnings increased 0.6%, which is a good portent for consumer spending potential. Over the last 12 months, average hourly earnings have risen 2.5% versus 2.3% in September.

The average workweek was 34.5 hours (Briefing.com consensus 34.5) versus 34.5 hours in September. Manufacturing workweek increased 0.1 hours to 40.7 hours. Factory overtime increased 0.1 hours to 3.3 hours. The labor force participation rate was unchanged at 62.4% the same as in September.

Establishment Survey
Nonfarm Payrolls 271K 137K 153K 223K 245K
  Goods-Producing 27K -10K -21K 7K -3K
    Construction 31K 12K 8K 5K 1K
    Manufacturing 0K -9K -19K 11K 1K
  Service-Providing 241K 159K 146K 188K 221K
    Retail Trade 44K 6K 4K 29K 36K
    Financial 5K 0K 14K 15K 21K
    Business 78K 33K 35K 40K 68K
       Temporary help 25K 3K 6K -11K 20K
    Education/Health 57K 46K 56K 42K 61K
    Leisure/Hospitality 41K 51K 37K 32K 19K
    Government 3K -12K 28K 28K 27K
Average Workweek 34.5 34.5 34.6 34.6 34.5
 Production Workweek 33.7 33.6 33.7 33.7 33.7
Factory Overtime 4.3 4.2 4.3 4.3 4.4
Aggregate Hours Index 0.3% -0.2% 0.1% 0.5% 0.2%
Avg Hourly Earnings 0.4% 0.0% 0.4% 0.2% 0.0%

After plenty of economic releases created doubts about the momentum of the US recovery, including the September employment report, the October employment report will solidify the view that the US economy is holding up just fine amid the stresses of economic slowdowns abroad.


Consumer credit increased by $ 28.9 billion in September, up from a $ 16 billion increase in August. The Briefing.com consensus expected consumer credit to increase by $ 18.0 billion.


The U.S. trade deficit narrowed in September to $40.8 billion from an upwardly revised $48.0 billion (from -$48.3 bln) in August. That was better than the $43.0 billion deficit projected by the Briefing.com consensus. The improvement in September was owed to imports being $4.2 billion less than August imports and exports being $3.0 billion more than August exports.  The decrease in the goods and services deficit was paced by a $7.3 billion decrease in the goods deficit and a $0.1 billion decrease in the services surplus.

The drop in imports was surprisingly broad-based given the dollar’s strength and didn’t exactly connote an element of strong demand in the US.

Trade Deficit -$40.8B -$48.0B -$41.8B -$45.2B -$42.5B
  Exports $187.9B $184.9B $188.8B $187.7B $187.9B
  Imports $228.7B $233.0B $230.6B $232.9B $230.4B

The bump in exports came primarily from consumer goods (+$1.28 bln), which was led by increases in artwork, jewelry, and cell phones, and a $0.89 billion increase in capital goods, excluding autos.  Imports of industrial supplies and materials fell by $1.58 billion, the bulk of which was related to crude oil (-$1.28 bln), capital goods dropped by $1.04 billion, auto imports decreased by $0.84 billion, consumer goods declined by $0.44 billion, and imports of other goods were down $0.49 billion.

Market Strategies Cycles


Way back in 1986 when Yale Hirsch, creator of the Stock Trader’s Almanac, first published his discovery that the market makes the majority of it gains in just six months of the year, he simple dubbed the pattern the “Best Six Months.” By analyzing monthly performance figures for DJIA and S&P 500 he noted a clear pattern that repeated rather consistently year after year, the bulk of the markets advance was made in the months from November to April. These six months combined have produced an average DJIA gain of 7.5% since 1950 compared to an average gain of just 0.4% during the months May to October. This market pattern is often associated with “Sell in May” or referred to as the Halloween indicator. We prefer the “Best Six Months” and the period just started this past Monday.


October 2015 was the best month for the market since October 2011. DJIA advanced 8.5%, S&P 8.3%, NASDAQ 9.4% and Russell 2000 was up 5.6%. DJIA gained 1379.54 point in the month, just the third month in history to eclipse 1000 points. October 2011 and April 1999 were the other two. Stellar performance like this tends to spur substantial debate. What happens next? Has the market borrowed from November and December? What will the rest of the year look like? We first looked at the subject on October 14 when S&P 500 was up 4.4% and then took a second look on October 26 when S&P 500 was closing in on an 8% gain. That second look included a narrowly focused historical look at the 30 trading days before the first trading day in November and the 60 trading days after. That research showed that past stellar Octobers were followed by below average gains for November to December of 1.9%. It also highlighted a rather tepid November and first half of December that eventually lead to a solid 7% move from around mid-December to early January.


In the next two charts, DJIA, S&P 500, NASDAQ and Russell 2000 average performance in November is plotted. The first chart is the most recent 21-year period spanning 1994 to 2014. In this chart, November opens strong, peaks around the fourth trading day, trades lower till the eighth trading day, bounces mid-month, moves sideways to lower during the week before Thanksgiving then higher to close out the month with gains ranging from just under 1.5% for Russell 2000 to over 2% for DJIA.


In a typical pre-election year, like 2015, November’s pattern is similar in shape, but average gains dwindle. NASDAQ (since 1971) and Russell 2000 (since 1979) lead and finish with a gain of slightly less than 1%. DJIA and S&P 500 finish the month with average gains of just 0.29%.


The combination of a big October gain and typical pre-election weakness in November suggests a tepid month this time around. However, this combo also presents an opportunity to buy any weakness ahead of Thanksgiving or around mid-December for a potentially solid rally in January 2016.


No new sector trades begin in the month of November. Oil’s seasonal weak period that typically begins in September does come to an end at the start of November. PowerShares DB Energy (DBE) was shorted as a way to take advantage of seasonal weakness in heating oil which overlapped with oil stock weakness. DBE reached a low of 12.83 on October 27 and has been rallying since. At yesterday’s close this short trade was barely positive and today’s big move is going to result in the position being stopped out. Recent oil market volatility suggests there may be an opportunity to exit this short trade closer to break even than at today’s level. Officially, DBE’s final return will calculated in the next ETF Portfolio update.


Previously mentioned October strength has lifted the ETF Portfolio Open Position Average to 7.7%. iShares US Tech (IYW), iShares DJ US Telecom (IYZ), SPDR Materials (XLB) and iShares NASDAQ Biotech (IBB) are all showing double-digits gains and are currently on Hold. SPDR Financial (XLF) and SPDR Healthcare (XLV) are up 6.7% and 7.4% respectively and are also on Hold.


Core four positions in DIA, IWM, QQQ and SPY, used to trade our Tactical Seasonal Switching Strategy (Best Six/Eight Months) are currently up 6.4% on average and are on Hold as well.


Open trade ideas, IYT, SOXX, XLK and VNQ can be considered on dips. Buy limits and auto-sell prices for these positions have been updated to account for recent moves. Should the market take a breather this month or early December as market history suggests it may do, we will look to use any dip then to add to existing positions or establish new long positions in the remaining



NOTE: This is a Sample Issue Only!



Visit: PrincetonResearch.com/join.htm



For Free Where To Invest Your Money Now

High Return Investments Trade Alerts

Go To: PrincetonResearch.com/alerts.htm

Where to invest Stocks to buy

Undervalued Small Cap Stocks


Lower Priced stocks that look to be a buy:


Repro-Med Systems, Inc ( OTCQX:  REPR 0.36 )* 


REPR is now a member of the OTCQX, a leading U.S. Stock Exchange.


Repro-Med Systems is a unique U.S. manufacturer of proprietary and patented medical devices world-wide which maintains offices and manufacturing facilities in Chester, NY.  Principal products include the Freedom 60 Syringe Infusion System, RMS High-Flo Subcutaneous Safety Needle Sets and the RES-Q-VAC Medical Suctioning Pump. In addition to being regulated by the FDA which has the authority to approve medical devices for marketing in the U.S., RMS complies with ISO International standards for quality development and manufacturing. RMS Medical Products is a d/b/a of Repro-Med Systems, Inc which was founded in 1980.


The Freedom60 has a proprietary technology that makes it desirable for the delivery of medications in a variety of therapies.  It is very popular for the delivery of subcutaneous immunoglobulin for the treatment of primary immune deficiency disease. The infusion pump uses “dynamic equilibrium” which safely adjusts the flow of medication in accordance with what the patient’s body can accept. This minimizes complications often encountered with other infusion systems which can lead to site reactions and discomfort for the patient. The portability and simple operation of the FREEDOM60 Improves quality of life for patients who otherwise might have to use a complicated electronic pump mounted to a cumbersome infusion pole. Patients then don’t have to be confined.


RMS High-Flo Subcutaneous Safety Needle Sets are being welcomed by healthcare providers and patients alike for their consistently high quality. The infusion sets are an ideal companion for the company’s FREEDOM 60 pump. The needle sets are patented and approved by the FDA. There has not been a new technology in needles other than Repro Med’s vastly better needle sets in quite some time.


RES-Q-VAC is a hand-held suction pump used to clear a patient’s airway or for other purposes when reliable hospital quality suctioning is needed. It uses patented technology to protect users from airborne pathogens and spillage of suctioned material. It is used by emergency service personnel and other first responders, as well as in hospitals and other institutions. There also is a version for use by dentists. RES-Q-VAC is invaluable in the event  of disasters where power is lost because it doesn’t require electricity.


The Freedom 60 Syringe Infusion System is a method for administering medication through a small needle to the subcutaneous tissue, which is the fatty tissue just under the skin. Subcutaneous infusion allows medication into the vascular system more slowly. Combined with more frequent delivery this provides more consistent and stable blood levels. The elimination of large swings in these levels decreases side effects improving overall quality of life. RMS provides High-Flo needles to optimize liquid flow. Their smaller 26 gauge high flow needle flows at the same rate as the considerably larger 24 gauge needles, which are considerably less painful when entering the skin.

The Freedom 60 has had great success in Europe reflected in a huge sales increase of 47.8% first quarter 2015 up from same quarter 2014.


Repro-Med Systems, Inc has had an increase in sales each of the last four years. They finished the year of 2014 with $ 11.2 million in sales reflecting top line growth of  29% from 2013.In each of the previous two years they had a 12% increase in sales. The company has had at least $ 700 thousand of net income in each of the past four years and has no debt. The patented needle sets alone can give the company a huge growth potential. In my opinion, with new products coming on stream, the stock should trade between $ 3 and $ 8 in the next two years.


Enzo Biochem ( ENZ 3.92 ) Bought at our price of $ 2.78. 


This turbulent market has had an effect on the price of Enzo Biochem. The markets, in my opinion, have been in a rotating correction and in some instances, a bear market for some months. It appears that the cause of this is China but I am sure that there are other factors. If you remember the ‘flash crash” of 2010 the market correction was over quickly and those that held through that market decline profited handsomely over the years after the crash. I think that the market is giving us another chance to buy Enzo Biochem at a bargain price. The Company’s fiscal year was over July 31. I would imagine the Quarter and Year results will be made available by mid-October. With the cash settlement in two litigations the cash position should show a major improvement. Top line revenues should also show an improvement. Depending on R&D expenses and litigation expenses the net loss should also show improvement. At today’s price of $2.90 the Company is valued at approximately $130 million and with revenues approaching $100 million or 1.3 times revenues. The last Craig Hallum report had a fair value of Enzo’s business of $6 per share. When AmpiProbe is approved and into the market that number is projected at $14 per share. There is always risk in the market so the investment is not without risk but if held over time should deliver handsome profits off of today’s price. Items to look forward to by the end of the year would be litigation news and an AmpiProbe decision all of which should have a positive impact on the stock price.


ProtoKinetix, Incorporated ( PKTX: 0.08  ) 

The “Company” or “ProtoKinetix” (www.protokinetix.com) trading at $ 0.0521 low and 0.0969 high on Friday has a huge upside potential. They are in collaboration with the James Shapiro laboratory at the University of Alberta. The sole intention of the collaboration is to develop a commercial product pipeline of therapeutic applications for the AAGP™ family of molecules.

Professor James Shapiro is Professor of Surgery, Medicine and Surgical Oncology, and Director of the Clinical Islet Transplant Program and the Living Donor Liver Transplant Program at the University of Alberta in Edmonton, Canada. He has a busy hepatobiliary surgical practice in HPB oncology, and in liver and kidney-pancreas transplant surgery. His center carries out 80 liver transplants per year, and has done around 80 living donor liver transplants. The University of Alberta just celebrated their 1000th liver transplant.

Dr. Shapiro directs the largest clinical islet transplant program worldwide with almost 170 patients treated, and led the clinical team that developed the “Edmonton Protocol” – the first trial to achieve consistent 100% insulin independence in a series of islet-alone transplant recipients with Type 1 diabetes (published in the NEJM 2000). Before Dr. Shapiro’s trial, the success rate with islet transplantation was less than 8%. He led an international multicenter trial to replicate these findings in 9 international centers (published in NEJM 2006).

Over the last 32 months Dr. Shapiro and his team have been extensively testing the AAGP™ molecule in allogeneic transplants using  human islet cells as the model. As regenerative medicine is rapidly becoming adopted in the treatment of degenerative diseases, the protection of the transplanted cells, tissues, and organs is of paramount importance. Transplanted cells and tissues are subjected to extreme stress factors that, unless protected, could cause failure to graft or premature death. The success of the tests conducted in Edmonton have demonstrated that AAGP™ has the potential to be widely adopted in many areas of regenerative medicine.


International Star, Inc. (OTC: “ILST”)

is pleased to announce that the company’s management team will host an Investor Presentation/Reception at the historic Golden Nugget in Las Vegas, NV on November 15, followed by a tour of the Van Deemen gold project outside of Kingman, Arizona on November 16.

Key topics for discussion will be the recently announced technical report/resource estimate, ongoing permitting efforts and financing. The management team will be available to meet with investors and answer questions regarding the project. At the mine tour, we will be fortunate to have Bud Hillemeyer, one of the original stake holders in the Van Deemen project in the 1980s and the 2010 recipient of prestigious PDAC Thayer Lindsley International Mineral Discoveries Award, speak to investors on his involvement with the Van Deemen project.

For additional details and to sign up for either the presentation or tour, visit https://www.regonline.com/ilstinvestormeeting_1773285. Both events are free, however RSVP is required. Please note that space for the mine tour is limited, therefore your earliest confirmation is appreciated.

International Star CEO Michael Shea commented: “Management is excited to meet shareholders and potential investors and provide the opportunity to visit the Van Deemen gold project. Our goal is to demonstrate the viability of the project and management’s capability to bring the mine online. As CEO, my most important commitment is to build value for my shareholders. To this end ILST is aggressively expanding our shareholder base as well as working with the legal team to enact creative programs that will reward shareholders of record.”

About International Star: (www.ilstholdings.com)



Fundamental Analysis Stocks To Buy with Stops


The HDGE continued to decline last week falling  well-below our 11.04 buy level,  the  barrier between bear and bull markets. We would look to buy with a stop loss at 10.28. It is high risk but a possible hedge against some of our successful longs like LUV and URI.


HDGE is the BEAR hedge.  We now want to be long stocks at their respective limits. Buy Intel on dips and Arcelor Mital.  We bought CVS and  were stoped out for a loss of  3.30 points.


We always use stops. Keep losses small. We are long Southwest Air (LUV) at 30.50, United  Rentals at  64.34 and Sunoco at 36.08  We bought Virgin Air (VA) at 32.20. Please check on the previous weekly market letters if there are questions.  We are long in Diana Shipping at 6.60.


DSX is a bear market opportunity with a small risk.  We are long Bank of America  at 15.65. and would use 15.02  as a stop loss . BAC looks to have made a double bottom at  the 14.63 area.


   Heavy Black italicized indicates Execution


Symbol Name Business Description


PE P/S MV mln Price Buy Limit Stop Loss

Or sold

SUN Sunoco Retail Sale Fuels 14 0.26   3B  36.0  36.08 32.71x
URI United Rentals Equipment Rental 8 1.13 15B 79.84 64.34 62x
DE Deere Farm and Construction equipment 13 0.84 26.3B 77.51 77.50 76.77x
KR Kroger Food Mfg and Processing 18 0.33 37B 37.57 36.76 33.40x
CVS CVS Health Pharmacy Sundries and drug store 18 0.79 116B 99.70 102.35 99x
MT Arcelor Mittal Integrated Steel mining and manufacturing 16.8 0.14 11.10B   5.43 5.80 5.22x
INTC Intel Technology chips platforms processors 13.6 2.8 152.83B 33.84 30.48 28.50
VA Virgin Air Regional Airlines 7.2 1.0 1.5B 38.36 32.20 29.50
LUV Southwest Air Regional Airlines 16 1.15 22.6B 46.85 33 32.31sco
ENZ Enzo Biochem Life Sciences NA 1.35 134M  3.92 2.78 3.28x
BAC Bank of America Commercial Bank 10 2.02 165.3B 17.95 15.65sco 15.02x
HDGE Advisor Shares Ranger Bear ETF 10.20 11.04 X 11.00X
DSX Diana Shipping Dry Cargo Shipping N/A 3.7 611  6.21 6.60 5.90


NOTE: This is a Sample Issue Only!



Visit: PrincetonResearch.com/join.htm

Where to Invest newsletter

For Free Where To Invest Your Money Now

High Return Investments Trade Alerts

Go To: PrincetonResearch.com/alerts.htm

Rule 17B Attestations and Disclaimer

Princeton Research, Inc. has approximately 2,581,578 shares of AIVN both free and restricted and represents them for Investor relations. Princeton also has about 40,000 shares of TXGE. Princeton is paid $ 1,500 per month from RMS Medical Products. Princeton has bought 81,100 shares of RMS Medical Products. Princeton was paid $ 2,500 to write a report on Xinergy. Princeton has signed a contract with CBLI to be paid $ 2500 for July and August for investor relations. Princeton has been engaged by Target Energy. No contract is currently in place. Princeton was paid about 500,000 restricted shares of Leo Motors.


When there is no movement in penny stocks, even though there is none or very small losses, we will liquidate ( sold AIVN on stop ) even though we like the company, if money is needed for better opportunities.


We now believe REPR represents upside opportunity. The Target ADR trades at about $ 4.50 in U.S. vs 0.05 in Australia. Princeton owns 400,000 Australia shares and about 900 U.S. ADR’s.


Pursuant to the provisions of Rule 206 (4) of the Investment Advisers Act of 1940, readers should recognize that not all recommendations made in the future will be profitable or will equal the performance of any recommendations referred to in this e-mail issue. Princeton may buy or sell its free-trading shares in companies it represents at any time.



Please Direct All Inquiries To:

Mike King

(702) 650-3000



Charles Moskowitz

 (781) 826-8882





Options Trading Newsletter